Medical Cannabis Clinical Trials - Minnesota Dept. of Health

Medical Cannabis Clinical Trials

The US National Institutes of Health maintains a website that reports publicly and privately supported clinical studies of human participants conducted around the world: ClinicalTrials.gov.

The website has a search mechanism that allows persons to search for trials of interest to them, for example “Crohn’s Disease” and “cannabis”. The search produces a list of studies that meet the search criteria: completed studies, studies currently enrolling patients, and studies still in the planning stage. 

Per Minnesota 2014 Statute 152.24, the Office of Medical Cannabis (OMC) will list in a section of the website clinical trials involving qualifying medical conditions in the Minnesota Medical Cannabis Program that have a study site in Minnesota. Below are the studies OMC is now aware of that meet this criteria:

  • The Mayo Clinic is participating in clinical trials of cannabidiol for medication-resistant seizures in very specific patient populations. A subset of children and young adults with Dravet’s Syndrome or Lennox-Gastaut Syndrome will be eligible. For more information, contact pediatricepilepsyresearch@mayo.edu.
Updated Wednesday, June 14, 2017 at 09:33AM